Bonk (BNKK) versus The Competition Financial Analysis

Bonk (NASDAQ:BNKK) is one of 343 public companies in the “Financial Services” industry, but how does it compare to its competitors? We will compare Bonk to similar companies based on the strength of its institutional ownership, earnings, dividends, risk, valuation, profitability and analyst recommendations.

Risk and Volatility

Bonk has a beta of 2.04, meaning that its stock price is 104% more volatile than the S&P 500. Comparatively, Bonk’s competitors have a beta of 2.20, meaning that their average stock price is 120% more volatile than the S&P 500.

Insider and Institutional Ownership

12.6% of Bonk shares are held by institutional investors. Comparatively, 43.2% of shares of all “Financial Services” companies are held by institutional investors. 51.6% of Bonk shares are held by company insiders. Comparatively, 22.1% of shares of all “Financial Services” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Bonk and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bonk	-952.21%	-137.47%	-122.67%
Bonk Competitors	-408.40%	-22.66%	-5.73%

Analyst Recommendations

This is a summary of recent ratings for Bonk and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bonk	1	0	0	0	1.00
Bonk Competitors	1912	6757	11451	418	2.51

As a group, “Financial Services” companies have a potential upside of 4.48%. Given Bonk’s competitors stronger consensus rating and higher possible upside, analysts plainly believe Bonk has less favorable growth aspects than its competitors.

Earnings and Valuation

This table compares Bonk and its competitors top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Bonk	$2.12 million	-$68.19 million	-0.40
Bonk Competitors	$6.31 billion	$1.08 billion	9.04

Bonk’s competitors have higher revenue and earnings than Bonk. Bonk is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Bonk competitors beat Bonk on 12 of the 13 factors compared.

About Bonk

Safety Shot, Inc., a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023. The company was incorporated in 2018 and is headquartered in Jupiter, Florida.